Loading…

GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors

AbstractBackground and AimHFE-related Hemochromatosis (HH) is characterized by marked phenotype heterogeneity, probably due to the combined action of acquired and genetic factors. Among them, GNPAT rs11558492 was proposed as genetic modifier of iron status, but results are still controversial. To sh...

Full description

Saved in:
Bibliographic Details
Published in:Annals of hepatology 2017-05, Vol.16 (3), p.451-456
Main Authors: Greni, Federico, Valenti, Luca, Mariani, Raffaella, Pelloni, Irene, Rametta, Raffaela, Busti, Fabiana, Ravasi, Giulia, Girelli, Domenico, Fargion, Silvia, Galimberti, Stefania, Piperno, Alberto, Pelucchi, Sara
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63
cites cdi_FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63
container_end_page 456
container_issue 3
container_start_page 451
container_title Annals of hepatology
container_volume 16
creator Greni, Federico
Valenti, Luca
Mariani, Raffaella
Pelloni, Irene
Rametta, Raffaela
Busti, Fabiana
Ravasi, Giulia
Girelli, Domenico
Fargion, Silvia
Galimberti, Stefania
Piperno, Alberto
Pelucchi, Sara
description AbstractBackground and AimHFE-related Hemochromatosis (HH) is characterized by marked phenotype heterogeneity, probably due to the combined action of acquired and genetic factors. Among them, GNPAT rs11558492 was proposed as genetic modifier of iron status, but results are still controversial. To shed light on these discrepancies, we genotyped 298 Italian p.C282Y homozygotes and 169 healthy controls. Material and MethodsAllele and genotype frequencies were analysed and compared with those reported in Exome Variant Server (EVS). To explore the role of rs11558492 as a potential modifier of iron status, serum ferritin (SF), liver iron concentration (LIC) and iron removed (IR) were studied according to allele and genotype frequencies. In addition, the effect of the SNP on liver fibrosis was examined comparing patients with absent/mild-moderate fibrosis to those with severe fibrosis-cirrho-sis. ResultsGNPAT rs11558492 minor allele (G) frequency (MAF) was 20.3% in HFE-HH, 17.2% in controls and 20.6% in EVS database. Genotype frequencies were 64% and 69.2% (AA), 31.2% and 27.2% (AG), 4.8% and 3.6% (GG) in HFE-HH and controls, respectively. No significant differences were found comparing genotype and allele frequencies even selecting subgroups of only-males with extreme phenotypes and low alcohol intake. SF, IR and LIC levels did not significantly differ according to rs11558492 genotypes. Also, MAF did not differ between patients with absent/mild fibrosis and severe fibrosis/cirrhosis. ConclusionsOur findings indicate that GNPAT rs11558492 is not a major modifier of iron status and is not associated with liver fibrosis in HFE-HH patients.
doi_str_mv 10.5604/01.3001.0009.8601
format article
fullrecord <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_22a550f4830b4e8abbb5e878a0146285</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1665268119304193</els_id><doaj_id>oai_doaj_org_article_22a550f4830b4e8abbb5e878a0146285</doaj_id><sourcerecordid>28425416</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63</originalsourceid><addsrcrecordid>eNo9kc9uFDEMh-cAoqXwAFxQXmAXO_8mwwGptNCu1EKllnPkySSQZXZSJbNI-_ZkutCLLVn2J_n3Nc07hLXSID8ArgXUAgDd2mjAF80paq1WXBs8aV6XsgWQQiF_1ZxwI7mSqE-bcvXt7vyB5YKolJEdZ7GwKc2M2C1tU2a3aYgh-sxSYJucJnY_07wvH2vfD4en6UxjpIld-11yv3La0ZxKpdzRHP00F0bTwD6PKQ3sMk0plzfNy0Bj8W__9bPmx9cvDxfXq5vvV5uL85uV422LKzQDl0o7iYEHlA54C6JteyXAmWA60QUhoAeujAA5KBeGtm0NahImcNLirNkcuUOirX3McUf5YBNF-zRI-aelPEc3ess5KQVBVlIvvaG-75U3rSFAqblRlYVHlsuplOzDMw_BLgIsoF0E2EWAXQTUm_fHm8d9v_PD88X_9OvCp-OCryn8qSFbN8YpOhp_-4Mv27TPUw3Ioi3cgr1ffC46sasP1yL-ApCzk3c</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors</title><source>ScienceDirect Journals</source><creator>Greni, Federico ; Valenti, Luca ; Mariani, Raffaella ; Pelloni, Irene ; Rametta, Raffaela ; Busti, Fabiana ; Ravasi, Giulia ; Girelli, Domenico ; Fargion, Silvia ; Galimberti, Stefania ; Piperno, Alberto ; Pelucchi, Sara</creator><creatorcontrib>Greni, Federico ; Valenti, Luca ; Mariani, Raffaella ; Pelloni, Irene ; Rametta, Raffaela ; Busti, Fabiana ; Ravasi, Giulia ; Girelli, Domenico ; Fargion, Silvia ; Galimberti, Stefania ; Piperno, Alberto ; Pelucchi, Sara</creatorcontrib><description>AbstractBackground and AimHFE-related Hemochromatosis (HH) is characterized by marked phenotype heterogeneity, probably due to the combined action of acquired and genetic factors. Among them, GNPAT rs11558492 was proposed as genetic modifier of iron status, but results are still controversial. To shed light on these discrepancies, we genotyped 298 Italian p.C282Y homozygotes and 169 healthy controls. Material and MethodsAllele and genotype frequencies were analysed and compared with those reported in Exome Variant Server (EVS). To explore the role of rs11558492 as a potential modifier of iron status, serum ferritin (SF), liver iron concentration (LIC) and iron removed (IR) were studied according to allele and genotype frequencies. In addition, the effect of the SNP on liver fibrosis was examined comparing patients with absent/mild-moderate fibrosis to those with severe fibrosis-cirrho-sis. ResultsGNPAT rs11558492 minor allele (G) frequency (MAF) was 20.3% in HFE-HH, 17.2% in controls and 20.6% in EVS database. Genotype frequencies were 64% and 69.2% (AA), 31.2% and 27.2% (AG), 4.8% and 3.6% (GG) in HFE-HH and controls, respectively. No significant differences were found comparing genotype and allele frequencies even selecting subgroups of only-males with extreme phenotypes and low alcohol intake. SF, IR and LIC levels did not significantly differ according to rs11558492 genotypes. Also, MAF did not differ between patients with absent/mild fibrosis and severe fibrosis/cirrhosis. ConclusionsOur findings indicate that GNPAT rs11558492 is not a major modifier of iron status and is not associated with liver fibrosis in HFE-HH patients.</description><identifier>ISSN: 1665-2681</identifier><identifier>DOI: 10.5604/01.3001.0009.8601</identifier><identifier>PMID: 28425416</identifier><language>eng</language><publisher>Mexico: Elsevier</publisher><subject>Acyltransferases - genetics ; Adult ; Biomarkers - blood ; Blood Donors ; Case-Control Studies ; Female ; Ferritins - blood ; Gastroenterology and Hepatology ; Gene Frequency ; Genetic Association Studies ; Genetic Predisposition to Disease ; Glyceronephosphate O-acyltransferase ; Hemochromatosis - blood ; Hemochromatosis - diagnosis ; Hemochromatosis - enzymology ; Hemochromatosis - genetics ; Hemochromatosis Protein - genetics ; Hereditary hemochromatosis ; Heterozygote ; Homozygote ; Humans ; Iron - blood ; Iron overload ; Italy ; Liver - metabolism ; Liver Cirrhosis - blood ; Liver Cirrhosis - diagnosis ; Liver Cirrhosis - enzymology ; Liver Cirrhosis - genetics ; Male ; Middle Aged ; Phenotype ; Polymorphism ; Polymorphism, Single Nucleotide ; Risk Factors ; Serum ferritin</subject><ispartof>Annals of hepatology, 2017-05, Vol.16 (3), p.451-456</ispartof><rights>Fundación Clínica Médica Sur, A.C.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63</citedby><cites>FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28425416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Greni, Federico</creatorcontrib><creatorcontrib>Valenti, Luca</creatorcontrib><creatorcontrib>Mariani, Raffaella</creatorcontrib><creatorcontrib>Pelloni, Irene</creatorcontrib><creatorcontrib>Rametta, Raffaela</creatorcontrib><creatorcontrib>Busti, Fabiana</creatorcontrib><creatorcontrib>Ravasi, Giulia</creatorcontrib><creatorcontrib>Girelli, Domenico</creatorcontrib><creatorcontrib>Fargion, Silvia</creatorcontrib><creatorcontrib>Galimberti, Stefania</creatorcontrib><creatorcontrib>Piperno, Alberto</creatorcontrib><creatorcontrib>Pelucchi, Sara</creatorcontrib><title>GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors</title><title>Annals of hepatology</title><addtitle>Ann Hepatol</addtitle><description>AbstractBackground and AimHFE-related Hemochromatosis (HH) is characterized by marked phenotype heterogeneity, probably due to the combined action of acquired and genetic factors. Among them, GNPAT rs11558492 was proposed as genetic modifier of iron status, but results are still controversial. To shed light on these discrepancies, we genotyped 298 Italian p.C282Y homozygotes and 169 healthy controls. Material and MethodsAllele and genotype frequencies were analysed and compared with those reported in Exome Variant Server (EVS). To explore the role of rs11558492 as a potential modifier of iron status, serum ferritin (SF), liver iron concentration (LIC) and iron removed (IR) were studied according to allele and genotype frequencies. In addition, the effect of the SNP on liver fibrosis was examined comparing patients with absent/mild-moderate fibrosis to those with severe fibrosis-cirrho-sis. ResultsGNPAT rs11558492 minor allele (G) frequency (MAF) was 20.3% in HFE-HH, 17.2% in controls and 20.6% in EVS database. Genotype frequencies were 64% and 69.2% (AA), 31.2% and 27.2% (AG), 4.8% and 3.6% (GG) in HFE-HH and controls, respectively. No significant differences were found comparing genotype and allele frequencies even selecting subgroups of only-males with extreme phenotypes and low alcohol intake. SF, IR and LIC levels did not significantly differ according to rs11558492 genotypes. Also, MAF did not differ between patients with absent/mild fibrosis and severe fibrosis/cirrhosis. ConclusionsOur findings indicate that GNPAT rs11558492 is not a major modifier of iron status and is not associated with liver fibrosis in HFE-HH patients.</description><subject>Acyltransferases - genetics</subject><subject>Adult</subject><subject>Biomarkers - blood</subject><subject>Blood Donors</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Ferritins - blood</subject><subject>Gastroenterology and Hepatology</subject><subject>Gene Frequency</subject><subject>Genetic Association Studies</subject><subject>Genetic Predisposition to Disease</subject><subject>Glyceronephosphate O-acyltransferase</subject><subject>Hemochromatosis - blood</subject><subject>Hemochromatosis - diagnosis</subject><subject>Hemochromatosis - enzymology</subject><subject>Hemochromatosis - genetics</subject><subject>Hemochromatosis Protein - genetics</subject><subject>Hereditary hemochromatosis</subject><subject>Heterozygote</subject><subject>Homozygote</subject><subject>Humans</subject><subject>Iron - blood</subject><subject>Iron overload</subject><subject>Italy</subject><subject>Liver - metabolism</subject><subject>Liver Cirrhosis - blood</subject><subject>Liver Cirrhosis - diagnosis</subject><subject>Liver Cirrhosis - enzymology</subject><subject>Liver Cirrhosis - genetics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Phenotype</subject><subject>Polymorphism</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Risk Factors</subject><subject>Serum ferritin</subject><issn>1665-2681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9kc9uFDEMh-cAoqXwAFxQXmAXO_8mwwGptNCu1EKllnPkySSQZXZSJbNI-_ZkutCLLVn2J_n3Nc07hLXSID8ArgXUAgDd2mjAF80paq1WXBs8aV6XsgWQQiF_1ZxwI7mSqE-bcvXt7vyB5YKolJEdZ7GwKc2M2C1tU2a3aYgh-sxSYJucJnY_07wvH2vfD4en6UxjpIld-11yv3La0ZxKpdzRHP00F0bTwD6PKQ3sMk0plzfNy0Bj8W__9bPmx9cvDxfXq5vvV5uL85uV422LKzQDl0o7iYEHlA54C6JteyXAmWA60QUhoAeujAA5KBeGtm0NahImcNLirNkcuUOirX3McUf5YBNF-zRI-aelPEc3ess5KQVBVlIvvaG-75U3rSFAqblRlYVHlsuplOzDMw_BLgIsoF0E2EWAXQTUm_fHm8d9v_PD88X_9OvCp-OCryn8qSFbN8YpOhp_-4Mv27TPUw3Ioi3cgr1ffC46sasP1yL-ApCzk3c</recordid><startdate>201705</startdate><enddate>201705</enddate><creator>Greni, Federico</creator><creator>Valenti, Luca</creator><creator>Mariani, Raffaella</creator><creator>Pelloni, Irene</creator><creator>Rametta, Raffaela</creator><creator>Busti, Fabiana</creator><creator>Ravasi, Giulia</creator><creator>Girelli, Domenico</creator><creator>Fargion, Silvia</creator><creator>Galimberti, Stefania</creator><creator>Piperno, Alberto</creator><creator>Pelucchi, Sara</creator><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>201705</creationdate><title>GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors</title><author>Greni, Federico ; Valenti, Luca ; Mariani, Raffaella ; Pelloni, Irene ; Rametta, Raffaela ; Busti, Fabiana ; Ravasi, Giulia ; Girelli, Domenico ; Fargion, Silvia ; Galimberti, Stefania ; Piperno, Alberto ; Pelucchi, Sara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acyltransferases - genetics</topic><topic>Adult</topic><topic>Biomarkers - blood</topic><topic>Blood Donors</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Ferritins - blood</topic><topic>Gastroenterology and Hepatology</topic><topic>Gene Frequency</topic><topic>Genetic Association Studies</topic><topic>Genetic Predisposition to Disease</topic><topic>Glyceronephosphate O-acyltransferase</topic><topic>Hemochromatosis - blood</topic><topic>Hemochromatosis - diagnosis</topic><topic>Hemochromatosis - enzymology</topic><topic>Hemochromatosis - genetics</topic><topic>Hemochromatosis Protein - genetics</topic><topic>Hereditary hemochromatosis</topic><topic>Heterozygote</topic><topic>Homozygote</topic><topic>Humans</topic><topic>Iron - blood</topic><topic>Iron overload</topic><topic>Italy</topic><topic>Liver - metabolism</topic><topic>Liver Cirrhosis - blood</topic><topic>Liver Cirrhosis - diagnosis</topic><topic>Liver Cirrhosis - enzymology</topic><topic>Liver Cirrhosis - genetics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Phenotype</topic><topic>Polymorphism</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Risk Factors</topic><topic>Serum ferritin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Greni, Federico</creatorcontrib><creatorcontrib>Valenti, Luca</creatorcontrib><creatorcontrib>Mariani, Raffaella</creatorcontrib><creatorcontrib>Pelloni, Irene</creatorcontrib><creatorcontrib>Rametta, Raffaela</creatorcontrib><creatorcontrib>Busti, Fabiana</creatorcontrib><creatorcontrib>Ravasi, Giulia</creatorcontrib><creatorcontrib>Girelli, Domenico</creatorcontrib><creatorcontrib>Fargion, Silvia</creatorcontrib><creatorcontrib>Galimberti, Stefania</creatorcontrib><creatorcontrib>Piperno, Alberto</creatorcontrib><creatorcontrib>Pelucchi, Sara</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Greni, Federico</au><au>Valenti, Luca</au><au>Mariani, Raffaella</au><au>Pelloni, Irene</au><au>Rametta, Raffaela</au><au>Busti, Fabiana</au><au>Ravasi, Giulia</au><au>Girelli, Domenico</au><au>Fargion, Silvia</au><au>Galimberti, Stefania</au><au>Piperno, Alberto</au><au>Pelucchi, Sara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors</atitle><jtitle>Annals of hepatology</jtitle><addtitle>Ann Hepatol</addtitle><date>2017-05</date><risdate>2017</risdate><volume>16</volume><issue>3</issue><spage>451</spage><epage>456</epage><pages>451-456</pages><issn>1665-2681</issn><abstract>AbstractBackground and AimHFE-related Hemochromatosis (HH) is characterized by marked phenotype heterogeneity, probably due to the combined action of acquired and genetic factors. Among them, GNPAT rs11558492 was proposed as genetic modifier of iron status, but results are still controversial. To shed light on these discrepancies, we genotyped 298 Italian p.C282Y homozygotes and 169 healthy controls. Material and MethodsAllele and genotype frequencies were analysed and compared with those reported in Exome Variant Server (EVS). To explore the role of rs11558492 as a potential modifier of iron status, serum ferritin (SF), liver iron concentration (LIC) and iron removed (IR) were studied according to allele and genotype frequencies. In addition, the effect of the SNP on liver fibrosis was examined comparing patients with absent/mild-moderate fibrosis to those with severe fibrosis-cirrho-sis. ResultsGNPAT rs11558492 minor allele (G) frequency (MAF) was 20.3% in HFE-HH, 17.2% in controls and 20.6% in EVS database. Genotype frequencies were 64% and 69.2% (AA), 31.2% and 27.2% (AG), 4.8% and 3.6% (GG) in HFE-HH and controls, respectively. No significant differences were found comparing genotype and allele frequencies even selecting subgroups of only-males with extreme phenotypes and low alcohol intake. SF, IR and LIC levels did not significantly differ according to rs11558492 genotypes. Also, MAF did not differ between patients with absent/mild fibrosis and severe fibrosis/cirrhosis. ConclusionsOur findings indicate that GNPAT rs11558492 is not a major modifier of iron status and is not associated with liver fibrosis in HFE-HH patients.</abstract><cop>Mexico</cop><pub>Elsevier</pub><pmid>28425416</pmid><doi>10.5604/01.3001.0009.8601</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1665-2681
ispartof Annals of hepatology, 2017-05, Vol.16 (3), p.451-456
issn 1665-2681
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_22a550f4830b4e8abbb5e878a0146285
source ScienceDirect Journals
subjects Acyltransferases - genetics
Adult
Biomarkers - blood
Blood Donors
Case-Control Studies
Female
Ferritins - blood
Gastroenterology and Hepatology
Gene Frequency
Genetic Association Studies
Genetic Predisposition to Disease
Glyceronephosphate O-acyltransferase
Hemochromatosis - blood
Hemochromatosis - diagnosis
Hemochromatosis - enzymology
Hemochromatosis - genetics
Hemochromatosis Protein - genetics
Hereditary hemochromatosis
Heterozygote
Homozygote
Humans
Iron - blood
Iron overload
Italy
Liver - metabolism
Liver Cirrhosis - blood
Liver Cirrhosis - diagnosis
Liver Cirrhosis - enzymology
Liver Cirrhosis - genetics
Male
Middle Aged
Phenotype
Polymorphism
Polymorphism, Single Nucleotide
Risk Factors
Serum ferritin
title GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T06%3A01%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GNPAT%20rs11558492%20is%20not%20a%20Major%20Modifier%20of%20Iron%20Status:%20Study%20of%20Italian%20Hemochromatosis%20Patients%20and%20Blood%20Donors&rft.jtitle=Annals%20of%20hepatology&rft.au=Greni,%20Federico&rft.date=2017-05&rft.volume=16&rft.issue=3&rft.spage=451&rft.epage=456&rft.pages=451-456&rft.issn=1665-2681&rft_id=info:doi/10.5604/01.3001.0009.8601&rft_dat=%3Cpubmed_doaj_%3E28425416%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2771-18d2456c41f2f14c0270377b530c8f8939f330b0258304d5cfd777816a38f2a63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/28425416&rfr_iscdi=true